Gabriel Afram
Huddinge, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.
Journal: Cancer medicine
Published: June 12, 2023
Response to Caravita di Toritto and Rago.
Journal: European journal of haematology
Published: October 17, 2022
Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.
Journal: European journal of haematology
Published: May 25, 2022
Involved free light chain: an early independent predictor of response and progression in multiple myeloma.
Journal: Leukemia & lymphoma
Published: April 02, 2021
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.
Journal: Cell reports. Medicine
Published: March 30, 2021
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).
Journal: American journal of hematology
Published: March 02, 2021
Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment.
Journal: International journal of dermatology
Published: February 02, 2021
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.
Journal: European journal of haematology
Published: December 26, 2020
Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression.
Journal: American journal of hematology
Published: September 15, 2020
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
Journal: Annals of hematology
Published: June 09, 2020
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study.
Journal: Stem cells translational medicine
Published: March 06, 2020
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.
Journal: Medical oncology (Northwood, London, England)
Published: January 27, 2018
Last Updated: 09/26/2026